Sina as a Case Study in Triggers

 | Oct 24, 2013 | 6:00 PM EDT  | Comments
  • Comment
  • Print Print
  • Print
Stock quotes in this article:

sina

I like Sina (SINA) on the buy side as long as price continues to hold above the Oct. 9 swing low at $79.13. I've set up a symmetrical pullback in Sina where two standout Fibonacci price clusters come in above that recent low. 

The first zone came in at $83.08-$83.57, which included a 1.272 extension along with a couple of "symmetry" or 100% price projections of prior declines. The second zone is at the $81.05-$82.34 area. This zone also includes some symmetry projections along with a .786 retracement and a 1.618 extension of a prior swing.

So far, price is holding above zone No. 1, and it has triggered an entry on the buy side. There is also Fibonacci timing for a low that coincides with a test of this key support between Oct. 23 and 25. Let's look at the 15-minute chart trigger, for those of you who are still confused about using triggers for your entries against these Fibonacci price cluster zones!

What is a trigger anyway? For me, it is price action on a lower time frame chart that suggests it is worth placing a bet against one of the price zones. My basic trigger is what I look for after a key zone is tested and it holds. For a swing-trade entry, the aggressive trigger is on the 15-minute chart. I'm more willing to use the 15-minute trigger chart when we are looking at a nice trend trade with the 200- and 50-day simple moving averages on my side. This is the case in Sina.

Now looking at the 15-minute chart below, you can see two triggers on this chart. The first is John Carter's squeeze trigger, which fired off where I drew one of the arrows on the chart.  This was also triggered by the 8 ema crossing above the 34 ema, along with the fact that it took out a prior swing high, which is my typical trigger entry.

SINA Triggers
Dynamic Trader

Columnist Conversations

Index Chart of the Day: SPX and RUT Divergence SPX vs. RUT (YTD) View Chart »&nbs...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
The S&P 500 index finished the week unchanged, but the VIX was up 5%, the divergence sending a bit of a mi...
Weyerhaeuser has been struggling since testing the 2013 highs last month. The stock extended a powerful...

BEST IDEAS

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.